Read IDSA%20Call%20for%20Abstracts%202011.pdf text version

Call for Abstracts

he Infectious Diseases Society of America (IDSA), the hIV Medicine Association (hIVMA), and the Annual Meeting Program Committee invite you to submit original abstracts by May 18, 2011 to be considered for presentation at the 49th Annual Meeting of IDSA, October 20-23, 2011, in Boston, MA. the Program Committee is seeking to complement a vigorous and diversified program with cutting-edge, up-to-the minute research and clinical findings containing the most stringent and critically researched science. Abstracts are peer reviewed for outstanding quality and scientific content. the Annual Meeting provides numerous opportunities to have your research reviewed by colleagues and leaders in the field. It also provides an excellent opportunity for fellows in training who are particularly urged to submit their best research. Selected poster presentations will be featured in the popular Poster Discussion Round sessions, and selected abstracts will be awarded Society commendations. One of the most highly rated abstracts will also be slated for oral plenary presentation. this announcement includes information and guidance for preparing and submitting an abstract. Please read the instructions thoroughly, paying careful attention to details in order to ensure a successful abstract submission and to increase the likelihood that your abstract will be accepted. Abstracts must be submitted electronically through the IDSA website, www.idsociety.org. We look forward to your participation at the 49th Annual Meeting of IDSA in Boston. We hope to inspire you to work with us to make the Annual Meeting a best-ever learning experience in infectious diseases. See you in Boston.

t

Sincerely, Barbara D. Alexander, MD, FIDSA Chair, Annual Meeting Program Committee Duke University Durham, NC

Submit Your Abstract Online

Abstracts must be submitted online through the IDSA 2011 Abstract Submission site at www.idsociety.org. E-mails and word processed versions submitted outside the Abstract Submission program cannot be accepted. Corresponding authors will receive an e-mail confirmation that IDSA has received the abstract. Abstract Submission Deadline: Wednesday, May 18, 2011 (5 p.m. EDT) Note: the abstract submission deadline will be strictly enforced and no exceptions will be allowed. Submissions after the deadline will not be considered.

TECHNICAL ASSISTANCE

During normal business hours (8:30 a.m. to 6 p.m. Eastern U.S. time) call the main Conference Exchange number (401-334-0220). Anyone answering this number will be able to help you. For routine support outside of normal business hours, e-mail the Conference Exchange at [email protected] this mailbox is monitored periodically by technical support between 7 a.m. and 11 p.m. on weekdays, and between 8 a.m. and 11 p.m. on weekends.

2

IDSA 49th Annual Meeting

Abstract Guidelines

Superior quality of research, content, and presentation of the abstract are the main elements that will be considered by the Program Committee. Attention to the following instructions will significantly increase the likelihood of acceptance of your abstract submission. Please avoid having your abstract rejected due to technical reasons such as word count or figure overage. Due to the time constraints associated with organizing the Annual Meeting, there will be no appeal process and no opportunity to resubmit a rejected abstract. Program directors are requested to encourage fellows to submit high quality abstracts.

All submitting authors are required to do the following:

· Obtain approval in advance from all co-authors before placing their names on the abstract. Submission of an abstract denotes that co-authors as well as authors have read the abstract, take responsibility for its content, and approve that their names appear on the abstract. Failure to obtain approval from all authors will result in immediate rejection of the abstract. · Include a concise statement of the research under investigation and its objectives. Define all concepts and abbreviations at first use. · Describe experimental methods briefly (including relevant numbers of patients and/or microorganisms). · Describe specific findings and analysis of data. (Promises such as "to be completed" are not acceptable.) · Include specific conclusions, with supporting statistical analyses when appropriate. (Concluding statements such as "the results will be discussed" are not acceptable.) · Do not submit multiple abstracts on overlapping facets of the same project unless each abstract has important, novel information and clearly stands on its own. Repetitive abstracts will be rejected. · Abstracts must not be submitted if previously presented at a national or international meeting such as ICAAC, ASM, ShEA, CROI, or ECCMID. · Resolve any issues relating to patent matters before submitting the abstract. · Agree to IDSA's embargo and copyright policy. (See page 5.) · Provide disclosures of potential conflicts of interest and complete an attestation form. List any financial interests, assistance, or relationships with companies, supporters, or commercial products that are related to the research (for example, research support, grants, sponsors, stockholder, etc.). A response to this request must be provided for each author or author group before the abstract can be peer reviewed.

Resolution of Personal Conflicts of Interest

It is the policy of IDSA that all Annual Meeting faculty, abstract authors and staff disclose and resolve any real or apparent conflicts of interest relating to the topics of this educational activity. According to the Accreditation Council for Continuing Medical Education (ACCME) Essentials and Standards, IDSA must provide balance, objectivity, and scientific rigor in all sponsored educational activities accredited for continuing medical education (CME). the intent of the disclosure is to provide the audience with information on which they can make their own judgments on program content. the Infectious Diseases Society of America is accredited by ACCME to provide CME for physicians.

Types of Abstract Presentations

Poster Presentation

Poster sessions are abstracts that have been selected and grouped together by category/topics. Poster presentations give authors an opportunity to acquaint attendees and experts in the field with the fundamentals of their abstracts and research. Presenting authors are required to be present at their poster boards for one and a half hours on assigned dates.

Oral Presentation

the presenting author is expected to discuss his or her scientific research and summarize the data into a comprehensive 10-minute presentation, with five minutes for questions and answers. Presenting authors are required to use PowerPoint slides to accompany their oral presentations.

Call For Abstracts

3

Guidelines For Abstract Submission

Detailed instructions are provided online during the abstract submission process. Below are helpful instructions to prepare your abstract submission: · Abstracts should be no more than 1,950 characters or approximately 300-350 words; not including title, authors, and spaces. Use simple fonts. · Italics, underline, bold, superscript and subscript formatting, Greek characters (both upper and lowercase), scientific characters, charts, tables, and graphs are accepted. · Always include the abstract title, authors, affiliations, and text. · You may upload a file or copy and paste the text of your abstract from a word processing document or a clipboard directly into the online abstract box. · All fields must contain the requested information or the submission will not be complete. · Do not send multiple submissions of the same abstract. Duplicate abstracts will be rejected. Be sure to combine all new information into one abstract. · Always keep an original copy of your submitted abstract. Always proofread your abstract. Accepted abstracts will be published exactly as submitted. If English is not your first language, please have a fluent English speaker review your abstract.

Required Format

the following is required to complete the online submission. Detailed instructions are provided online during the abstract submission process. TITLE: Use a concise title that summarizes the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Italicize all specific/scientific names of microorganisms as appropriate. AUTHORS: Enter complete author(s) names (example: John S. Doe, MD). Include the name, degree, institution, city, state, and country of all authors and author groups. AFFILIATIONS: List the name of each author's institution, city, state, and country (do not include department, division, laboratory, etc.). Grant acknowledgments should not appear in abstracts, but should be included in the CME disclosures. Refer to page 7 for abbreviations. ABSTRACT TEXT: Describe the relevance of the research using background, methods, results, and conclusions. IDSA will not edit or revise the abstracts. Submitters/authors are responsible for the accuracy of the abstract text. We recommend that a colleague review the abstract for accuracy and grammar. SUBJECT CATEGORY: Select one subject category (refer to page 7 for a listing). Abstracts will be divided into categories for review and programming purposes. the Annual Meeting Program Committee reserves the right to reassign your abstract to a different category if deemed necessary. CONTACT INFORMATION: Provide all pertinent contact information to ensure that correspondence is received promptly and accurately. You must specify the "presenting author." IDSA will correspond with the presenting author using only the contact information that is provided at the time of submission. It is the responsibility of the presenting author to communicate future correspondence to all co-authors. KEY WORDS: Choose one to three key words in the menu (highest priority first). Additional key words are accepted but should be words in common usage, such as those used in Medline and Index Medicus. CHANGES/MODIFICATIONS: Changes/modifications, including author and affiliation changes, are allowed for submitted abstracts until the abstract submission deadline of May 18. No change whatsoever can be made after 5 p.m. EDT on May 18. Once you submit the abstract, a confirmation message will appear on the screen with an abstract tracking number assigned. Keep a record of your abstract tracking number until you receive your abstract disposition letter.

4

IDSA 49th Annual Meeting

informed that the abstract has either been accepted or rejected, and to disseminate the presentation scheduling information. If your abstract is accepted, you will receive guidelines for preparing poster or oral presentations. Please note that due to the large number of abstracts, IDSA will not consider special scheduling requests for poster or oral presentations. If you do not receive your notification by 5 p.m. on July 15, 2011, please contact Nathalie Gabriel at [email protected]

Late Breaker Abstracts

Only abstracts that contain new data that could not have been available at the time of the original abstract deadline may be submitted for consideration as late breaker abstracts. Late breaker abstracts are highly competitive; only abstracts containing new, novel, cutting-edge information will be considered. Retrospective studies will not be considered. Because of the nature of late breakers, IDSA will accept very few submissions for presentation, less than 10 percent. All late breaker abstracts must be submitted online at www.idsociety.org. Authors of late breaker abstracts are not eligible to apply for IDSA travel Grants or IDSA Awards. Late Breaker Abstract Submission Opens: Friday, May 27 Late Breaker Abstract Submission Deadline: Friday, August 12 (5 p.m., EDt) Note: Deadlines will be strictly enforced and no exceptions will be allowed. Submissions after the deadline will not be considered.

Withdrawal and Penalties

If you wish to withdraw an accepted abstract for any reason, you must send your request in writing by the withdrawal deadline of Friday, July 29, 2011. Withdrawal of an accepted abstract after July 29 or failure to present an accepted abstract could result in disqualification from presenting an abstract at the IDSA Annual Meeting for the subsequent year. Send your withdrawal letter by e-mail to: Nathalie Gabriel, Senior Manager, Meetings and Logistics Infectious Diseases Society of America E-mail: [email protected]

Embargo and Copyright Policy

Abstracts are considered official communications to the conference. the presenting author and co-authors must comply with the IDSA embargo policy that abstracts must be based on results that have not or will not have been published in any journal nationally or internationally, wholly or in part, before the 49th Annual Meeting of IDSA. Abstracts must not be submitted if previously presented at a national or international meeting such as ICAAC, ASM, ShEA, CROI or ECCMID. the Society will consider abstracts that have been previously submitted at smaller/regional meetings, but have not been published in a journal; however, all new or updated data must be included in the abstract. Authors and co-authors transfer any copyrights and agree to release the abstract for future IDSA publication and grant permission to IDSA to audio/video record oral presentations for later sale or publication. All abstracts must be embargoed until thursday, October 20, at 12:01 a.m. EDt, with the exception of research findings presented at IDSA press conferences.

Opportunities to Highlight Scientific Findings

Because accepted abstracts play a vital role in the IDSA Annual Meeting, we are pleased to highlight special features that combine quality science and innovative educational opportunities.

Poster Discussion Rounds

these popular sessions offer small-group discussions led by a recognized expert in an identified field. the discussion leader identifies posters detailing new scientific and clinical findings.

Named Lecture Plenary Oral Abstract

this is a unique opportunity for a select scientist to present during the Named Lecture Plenary session and will provide maximum exposure to the authors and their research. the author will be given 15 minutes to present his or her work and all accepted abstracts will be considered.

Disposition Notification

Abstract disposition notices will be sent Friday, July 15 via e-mail only to presenting authors. Abstract dispositions will not be provided over the telephone before this date. It is the responsibility of the presenting author to notify and ensure that all co-authors are

IDSA Press Conferences

Newsworthy research will be highlighted at the IDSA press conferences during the Annual Meeting. At the 2010 IDSA Annual Meeting, 521 stories were written with a reach of 65.8 million people.

Call For Abstracts

5

2011 IdSA Awards and Grants

IDSA is proud to offer grants acknowledging distinguished, quality scientific research presented at IDSA 2011. the IDSA Annual Meeting Program Committee will award these grants to support attendance and travel needs of candidates whose abstracts have been selected and who are scheduled to present their work at the IDSA Annual Meeting. IDSA Awards and Grants are applied for through the online abstract submission process. Only regular abstract submissions (not late breaker abstracts) are eligible. the requirements described below must be met in order to qualify. Only one award or grant is permissible per abstract/presenting author. of the accepted abstract and the confirmation letter from the applicant's program training director on the institution's letterhead. Minorities and women are encouraged to apply. An applicant must: · be a medical student, resident, or house officer; and · be the presenting author of an accepted abstract; and · submit a brief confirmation letter from the applicant's program director on the institution's letterhead.

IDSA Fellows' Travel Grants

IDSA is pleased to continue to provide support for ID fellows-intraining to attend the IDSA Annual Meeting. these grants will be awarded to fellows in training who submit excellent research. the Society will make available travel grants to each ACGME accredited program in adult and/or pediatric infectious diseases in the United States and Canada, as well as PharmD research training programs in infectious diseases. the amount awarded will be $1,000 for abstracts selected for presentation. Multiple fellows from the same training program can submit abstracts and apply for these awards. Only one grant per fellow will be given; however, there is no limit to how many fellows per program can receive a grant. Grants will be awarded until funding is exhausted. An applicant must: · be a PhD or MD enrolled in an ID Fellowship Program at time of application; · be an active member of IDSA at time of submission and presentation; · be a PharmD presently enrolled in a research fellowship in ID; or · be a PharmD presently enrolled in a graduate program in ID related research leading to a PhD; and · be the presenting author of an accepted abstract; and · submit a brief confirmation letter from the applicant's program director on the institution's letterhead.

Named Lecture Plenary Oral Abstract

IDSA will extend the Friday Named Lecture Plenary session for presentation of one original abstract. this unique opportunity to present during the Named Lecture Plenary session will provide maximum exposure to the author and his or her research. the selected author will be given 15 minutes to present his or her work. All accepted abstracts will be considered; selection will be based on the originality and impact of the work, and presentations by advanced trainees or junior faculty will be favored. the author of the selected abstract will be notified with his or her disposition.

2011 Program Committee Choice Awards

highlighting young investigators, up to four of the top abstracts in an open, overall category will be selected for an award of $2,500 each. IDSA's Annual Meeting Program Committee will select the recipients based on outstanding scientific research. Award recipients will receive recognition in the 2011 Final Program. An applicant must: · have an abstract accepted by the regular submission deadline (not a late breaker abstract); and · be the presenting author of the accepted abstract; and · be less than six years out of fellowship (includes Accreditation Council for Graduate Medical Education [ACGME] infectious diseases fellowships, PharmD fellowships, and post-doctoral research in infectious diseases).

Guerrant International Travel Grants

the Guerrant International travel Grants are awarded to international participants from developing countries (based on the World Bank list of low-income countries). A limited number of grants are available to participants whose abstracts have been accepted. $1,600 will be awarded for assistance with travel, hotel, and meal costs. An applicant must: · be the presenting author of an accepted abstract; and · be from a low-income country (based on the World Bank list).

Kass Awards

the Kass Awards were established to honor the achievements of Edward h. Kass, MD, who was a leader in infectious disease research. Up to four awards will be given in 2011 to medical students, residents, or house officers (not fellows) whose abstracts have been accepted (either poster or oral presentation) and who have demonstrated excellent research in infectious diseases and allied fields during the past year. Kass Award recipients will receive $750 to assist with Annual Meeting expenses such as travel, hotel, and meal costs. Awards will be given based on the excellent quality

6

IDSA 49th Annual Meeting

Subject Categories

International Young Investigator Award

Up to 10 awards are given to young investigators who submit excellent research. this award is $1,500 for international young investigators whose abstracts are selected for presentation at the Annual Meeting. An applicant must: · be the presenting author of an accepted abstract; · be under 40 years of age; and · be from outside the United States and Canada. A Antimicrobial Agents and Resistance B Bacterial Pathogenesis, Studies in Animal Models and Molecular Pathogenicity C Clinical Studies of Bacterial Infections and Antibacterials including Sexually transmitted Diseases and Mycobacterial Infections (Surveys, Epidemiology, and Clinical trials) D Diagnostic Microbiology E Innate and Adaptive Immunity to Infections, Including Vaccine Immunology h hIV/AIDS and Other Retroviruses I J Adult and Pediatric Vaccines Clinical Practice Issues

Call For Adult and Pediatric Cases

Fellows in U.S. infectious diseases training programs are invited to submit cases for presentation during one of two Fellows' Day Programs offered as premeeting workshops. Each fellow whose case is selected for presentation will receive an $800 travel grant. For additional details on requirements and how to submit cases, please visit www.idsociety.org/meetings.htm.

M Mycology Including Clinical and Basic Studies of Fungal Infections N hospital-Acquired and Surgical Infections, Infection Control, and health Outcomes Including General Public health and health Services Research O transplant Infectious Diseases P Pediatric and Perinatal Infections t travel/tropical Medicine and Parasitology V Virology Including Clinical and Basic Studies of Viral Infections Including hepatitis

How To Apply for Grants Award

Applications must be submitted online through the abstract submission site by May 18. Letters of program confirmation, when required, should be sent by facsimile to Nathalie Gabriel, IDSA, at (866) 579-0939 by May 18. For further details, visit the IDSA website at www.idsociety.org.

Abbreviations

Use the following abbreviations within affiliations for all authors. Use these abbreviations for plurals, adjectives, and foreign versions of these words. Abbreviate states using capital letters without periods (e.g., PA not Penn.). Administration ............................................................. Admin. Biology or Biological ........................................................ Biol. Center ................................................................................Ctr. Centers for Disease Control and Prevention .................... CDC Clinic or Clinical..............................................................Clin. College ............................................................................. Coll. Corporation ....................................................................Corp. Development.....................................................................Dev. Education........................................................................... Ed. U.S. Food and Drug Administration ........................ U.S. FDA Foundation .................................................................... Fndn. General ............................................................................ Gen. hospital(s) ..................................................................... hosp. Incorporated.......................................................................Inc. Institute(s) or Institution ...................................................Inst. International ..................................................................... Intl. Medical or Medicine ........................................................Med. Memorial ....................................................................... Mem. Microbiology or Microbiological ............................. Microbiol. National ...........................................................................Natl. National Cancer Institute ................................................. NCI National Institutes of health ............................................ NIh National Institute of Allergy and Infectious Diseases .... NIAID Public ...............................................................................Publ. Research ............................................................................ Res. School ............................................................................... Sch. Science(s) ........................................................................... Sci. University........................................................................ Univ. U.S. Department of Agriculture ................................. U.S. DA Veterans Administration .....................................................Vet.

Call For Abstracts

7

2011 Important dates

Abstract Submission Deadline ......................................... Wednesday, May 18* Deadline for Awards & Grants with Confirmation Letters ....................................................... Wednesday, May 18*! Late Breaker Abstract Submission Opens ........................ Friday, May 27 Abstract Disposition Notification .................................... Friday, July 15 Abstract Withdrawal Deadline ......................................... Friday, July 29 Late Breaker Submission Deadline .................................. Friday, August 12* Late Breaker Disposition Notification ............................. Friday, September 9

Registration

Early Registration Deadline ............................................. Friday, July 29 Regular Registration Deadline ......................................... Friday, September 23 49th Annual Meeting of IDSA ......................................... October 20-23 (Thursday - Sunday)

*5 p.m. Eastern Daylight time ! Applications for awards and grants must be submitted online only by May 18 during the abstract submission process. Confirmation letters should be sent by facsimile to (866) 579-0939.

1300 Wilson Blvd, Suite 300 Arlington, VA 22209 Phone: (703) 299-0200 Fax: (703) 299-0204 E-mail: [email protected] Website: www.idsociety.org

Information

8 pages

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

106662